HENDERSON MICHAEL THOMAS 内部人交易：近期 SEC Form 4 交易
过去 18 个月，HENDERSON MICHAEL THOMAS（CIK 1779990）在 2 家公司共报告 42 笔 SEC Form 4 内部人交易（最近一笔 2026-09-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 920,941 | $0 |
| 2026-07-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 20,000 | $2.7M |
| 2026-07-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 75,046 | $0 |
| 2026-06-24 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 80,000 | $10.6M |
| 2026-06-23 | Spyre Therapeutics, Inc. (SYRE) | 董事 | 卖出 | 20,000 | $2.0M |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 6,770 | $556,562 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 7,654 | $633,598 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 1,080 | $90,914 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 1,577 | $134,345 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 2,305 | $198,852 |
| 2026-06-12 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 614 | $53,350 |
| 2026-05-15 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 18,659 | $1.5M |
| 2026-05-15 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 1,341 | $110,740 |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | 董事 | 卖出 | 2,404 | $174,458 |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | 董事 | 卖出 | 33,513 | $2.5M |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | 董事 | 卖出 | 24,814 | $1.9M |
| 2026-05-08 | Spyre Therapeutics, Inc. (SYRE) | 董事 | 卖出 | 19,269 | $1.5M |
| 2026-04-20 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 买入 | 3,000 | $68,580 |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 17,800 | $1.5M |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 2,000 | $166,520 |
| 2026-04-10 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 200 | $17,000 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 8,363 | $621,287 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 8,219 | $615,028 |
| 2026-03-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 3,418 | $259,289 |
| 2026-02-13 | Apogee Therapeutics, Inc. (APGE) | Chief Executive Officer | 卖出 | 11,494 | $723,662 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03